Celularity Inc (CELU) bonds
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.05 (-7.99%)
Close on Nov 13, 2026Market cap $20.45MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Celularity reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Celularity's 10-Q for the period ended Jun 30, 2026
| Issue | Matures | Amount issued |
|---|---|---|
| December Two Thousand Twenty Five Convertible Note Convertible at $2 a share | Dec 31, 2026 | $3.00M |
| Convertible Promissory Note Convertible | – | $2.50M |
| December Two Thousand Twenty Five Promissory Note | – | $7.00M |
| Initial Loan | – | $6.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| December Two Thousand Twenty Five Convertible Note | – | $2.86M |
| June Two Thousand Twenty Six Promissory Note | – | $1.00M |
| Two Thousand Twenty Five Convertible Note | – | $2.69M |
| Two Thousand Twenty Five Promissory Note | – | $6.88M |
See a number that looks wrong?